IMMUNOGLOBULIN A NEPHROPATHY
Clinical trials for IMMUNOGLOBULIN A NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN A NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare kidney disease
Disease control Not yet recruitingThis study is testing an investigational drug called atrasentan in children and teenagers (ages 2 to 18) who have a kidney disease called IgA nephropathy. The main goal is to see if the drug safely reduces the amount of protein in the urine, which is a key sign of kidney damage. …
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:48 UTC
-
New antibody drug enters human testing for serious kidney disease
Disease control Not yet recruitingThis early-stage study aims to test the safety and effects of a new drug called MIL116, which is an antibody designed to target a protein involved in IgA nephropathy. It will first be given to healthy volunteers to check for safety, and then to patients with the kidney disease to…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY
Phase: PHASE1, PHASE2 • Sponsor: Beijing Mabworks Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC